The expanding role of the BCL6 oncoprotein as a cancer therapeutic target

Por Cardenas, Mariano G, Oswald, Erin, Yu, Wenbo, Xue, Fengtian, MacKerell, Alexander D., Melnick, Ari M.
Publicado no Clin Cancer Res (2016)

EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis

Por Béguelin, Wendy, Teater, Matt, Gearhart, Micah D., Calvo Fernández, María Teresa, Goldstein, Rebecca L., Cárdenas, Mariano G., Hatzi, Katerina, Rosen, Monica, Shen, Hao, Corcoran, Connie M., Hamline, Michelle Y., Gascoyne, Randy D., Levine, Ross L., Abdel-Wahab, Omar, Licht, Jonathan D., Shaknovich, Rita, Elemento, Olivier, Bardwell, Vivian J., Melnick, Ari M.
Publicado no Cancer Cell (2016)

Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma

Por Cardenas, Mariano G., Yu, Wenbo, Beguelin, Wendy, Teater, Matthew R., Geng, Huimin, Goldstein, Rebecca L., Oswald, Erin, Hatzi, Katerina, Yang, Shao-Ning, Cohen, Joanna, Shaknovich, Rita, Vanommeslaeghe, Kenno, Cheng, Huimin, Liang, Dongdong, Cho, Hyo Je, Abbott, Joshua, Tam, Wayne, Du, Wei, Leonard, John P., Elemento, Olivier, Cerchietti, Leandro, Cierpicki, Tomasz, Xue, Fengtian, MacKerell, Alexander D., Melnick, Ari M.
Publicado no J Clin Invest (2016)